Autopsy report · NCT00282581

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

“Senior managemnt decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 9 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Sanofi Pasteur, a Sanofi Company

Sponsor type

Industry

Conditions

HIV Infections; Smallpox

Interventions

MVA Smallpox Vaccine

Participants

2

Sites

6

Countries

United States

Trials that died the same way

• Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
  “Decisions made by senior management of the company” (83% match in meaning)
• Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
  “Management Decision” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.